Creative Medical Technology Holdings (CELZ) Net Income towards Common Stockholders (2010 - 2026)

Creative Medical Technology Holdings (CELZ) has reported Net Income towards Common Stockholders for 17 consecutive years, with -$1.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Net Income towards Common Stockholders fell 22.54% year-over-year to -$1.5 million in Q2 2026; TTM through Jun 2026 was -$7.3 million, a 5.55% decrease from a year earlier, with the FY2025 full-year figure at -$7.2 million, down 9.24% from the prior year.
• Net Income towards Common Stockholders was -$1.5 million for Q2 2026 at Creative Medical Technology Holdings, down from -$1.4 million in the prior quarter.
• Over five years, Net Income towards Common Stockholders peaked at -$982339.0 in Q3 2022 and troughed at -$6.2 million in Q4 2022.
• A 5-year average of -$1.8 million and a median of -$1.4 million in 2023 frame the typical range for Net Income towards Common Stockholders.
• Across the five-year window, Net Income towards Common Stockholders slumped 104.15% in 2022 and soared 72.99% in 2023, its largest moves.
• Over 5 years, Net Income towards Common Stockholders stood at -$6.2 million in 2022, then soared by 72.99% to -$1.7 million in 2023, then tumbled by 77.34% to -$3.0 million in 2024, then declined by 4.81% to -$3.1 million in 2025, then surged by 51.56% to -$1.5 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at -$1.5 million (Q2 2026), -$1.4 million (Q1 2026), and -$3.1 million (Q4 2025), per Business Quant data.